BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3948164)

  • 1. Interaction of cimetidine but not ranitidine with cyclophosphamide in mice.
    Dorr RT; Soble MJ; Alberts DS
    Cancer Res; 1986 Apr; 46(4 Pt 1):1795-9. PubMed ID: 3948164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of H2 antagonists cimetidine and famotidine on the hemotoxicity of cyclophosphamide.
    Lerza RA; Bogliolo GV; Mencoboni MP; Saviane AG; Pannacciulli IM
    Anticancer Res; 1988; 8(6):1241-5. PubMed ID: 2905881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H2-antagonists and carmustine.
    Dorr RT; Soble MJ
    J Cancer Res Clin Oncol; 1989; 115(1):41-6. PubMed ID: 2564000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of phenobarbital on cyclophosphamide antitumor activity.
    Alberts DS; van Daalen Wetters T
    Cancer Res; 1976 Aug; 36(8):2785-9. PubMed ID: 1277188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic basis for the interaction of cimetidine with the bone marrow stem cells (CFUS).
    Byron JW
    Exp Hematol; 1980 Mar; 8(3):256-63. PubMed ID: 6109639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of theophylline clearance by cimetidine but not ranitidine.
    Powell JR; Rogers JF; Wargin WA; Cross RE; Eshelman FN
    Arch Intern Med; 1984 Mar; 144(3):484-6. PubMed ID: 6322709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
    Warrington RC; Fang WD
    J Natl Cancer Inst; 1985 May; 74(5):1071-7. PubMed ID: 3858576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.
    Dal Negro R; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Turco P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
    Warrington RC; Muzyka TG; Fang WD
    Cancer Res; 1984 Jul; 44(7):2929-35. PubMed ID: 6722819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of histamine H2-receptor antagonists on hemopoietic reconstruction in bone marrow].
    Du XX; Zhou YJ; Xu YH
    Sheng Li Xue Bao; 1989 Dec; 41(6):597-601. PubMed ID: 2576333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of H2 blockers on blood levels of parathormones and calcitonin in normal subjects].
    Biagi P; Galli M; Brettoni A
    Minerva Med; 1985 Oct; 76(38):1745-50. PubMed ID: 2864665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
    Phelan ET; Vietti TJ; Valeriote FA; Coulter D
    Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic interaction between cimetidine, ranitidine and amitriptyline/chlordiazepoxide].
    Kurowski M; Reim HG
    Z Gastroenterol; 1986 Oct; 24(10):627-34. PubMed ID: 3788228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cimetidine enhancement of cyclophosphamide antitumour activity.
    Dorr RT; Alberts DS
    Br J Cancer; 1982 Jan; 45(1):35-43. PubMed ID: 7059463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of allopurinol on cyclophosphamide antitumor activity.
    Alberts DS; van Daalen Wetters T
    Cancer Res; 1976 Aug; 36(8):2790-4. PubMed ID: 1277189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cimetidine and ranitidine on local anesthetic central nervous system toxicity in mice.
    Kim KC; Tasch MD
    Anesth Analg; 1986 Aug; 65(8):840-2. PubMed ID: 3729019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
    Pazdernik TL; Uyeki EM
    J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
    Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
    Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
    Khandalekar DD; Ganu UK; Gokhale SV
    Indian J Physiol Pharmacol; 1989; 33(3):171-4. PubMed ID: 2592043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.